The company also plans to launch new advanced technologies to further support the utilization of Versius in 2024. These technologies include enhancements in vision, instrumentation and digital. Cambridge, UK-based CMR Surgical said in a news release that it aims to enter more new markets during the coming year.
CMR Surgical said it closed the year with its Versius global install base more than 50% higher than in 2022. It reports more than 17,000 surgical procedures completed with Versius during the year for growth of more than 60%.
Versius, a small-scale surgical robotic system, features collaborative arms and bedside units for direct patient access. It also features offers of port placement to best suit the needs of each patient. CMR Surgical designed Versius to enable surgeons to perform more minimal access surgery. Its minimally invasive approach assists surgeons accessing the lungs, thymus and esophagus.
Recent highlights include the latest Versius installation in Germany, announced last month. That means there have been more than 140 around the world to date. Expansion over 2023 included new markets such as Greece and Indonesia. CMR Surgical also raised $165 million to support Versius in September.
The company says it charged new CCO Massimiliano Colella with leading the further acceleration of Versius installations in 2024.
“As we enter our fifth year since the launch of Versius, this is a tremendously exciting time for CMR and our customers as we see the momentum for Versius, and robotic-assisted surgery grow exponentially,” CMR Surgical CEO Supratim Bose said. “Versius is a truly differentiated product that is helping more hospitals around the world offer robotic-assisted surgery. Additionally, the launch of new advanced technologies for Versius – across both hardware and software – will be a game-changer this year.
“We are already seeing Versius prove its use in complex surgeries, and with new products on the market, we look forward to working with our customers to expand the procedures that are performed using Versius, and welcome new hospitals in existing and new geographies, so that more patients can benefit from robotic-assisted surgery.”
